DISCLAIMER:
Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.
Taxonomy: TH- External Beam- Particle/high LET therapy: Dual energy/spectral CT-based stopping power mapping
| PO-GePV-M-138 | Feasibility of a Second-Generation Dual-Layer Spectral CT System for Stopping Power Prediction and Dose Calculation in Particle Therapy F Longarino1*, A Kowalewski2, T Tessonnier3, S Mein4, B Ackermann5, J Debus6, W Stiller7, A Mairani8, (1) German Cancer Research Center (DKFZ), Heidelberg, DE, (2) German Cancer Research Center (DKFZ), Heidelberg, DE, (3) Heidelberg Ion Beam Therapy Center (HIT), Heidelberg, DE, (4) German Cancer Research Center (DKFZ), Heidelberg, DE, (5) Heidelberg Ion Beam Therapy Center (HIT), Heidelberg, DE, (6) Heidelberg University Hospital, Heidelberg, DE, (7) Heidelberg University Hospital, Heidelberg, DE, (8) Heidelberg Ion Beam Therapy Center (HIT), Heidelberg, DE |
| PO-GePV-T-3 | Clinical Analysis of a Dual-Energy CT Joint Statistical Image Reconstruction Method in Proton Therapy X Chen1*, M Medrano2, T Ge3, R Liao4, D Politte5, B Whiting6, Y Hao7, J Williamson8, J O'Sullivan9, T Zhao10, (1) Washington University in St. Louis, St. Louis, MO, (2) Washington University in St. Louis, St. Louis, MO, (3) Washington University in St. Louis, St. Louis, MO, (4) Washington University in St. Louis, St. Louis, MO, (5) Washington university in St. Louis, St. Louis, (6) retired, Pittsburgh, PA, (7) Washington University School of Medicine, St. Louis, MO, (8) Washington University in St. Louis, St. Louis, MO, (9) Washington University, St. Louis, MO, (10) Washington University School of Medicine, St. Louis, MO |
| SU-H300-IePD-F5-1 | A Deep Learning Approach to Correct Scatter in Dual-Energy CBCT Data: Accuracy and Potential for Adaptive Proton Therapy A Lalonde*, B Winey, H Paganetti, G Sharp, Department of Radiation Oncology Massachusetts General Hospital and Harvard Medical School, Boston, MA |
| SU-I400-BReP-F2-2 | Clinical Implementation of DECT for Proton Therapy with Reduced Range Uncertainty Margins: Reproducibility and Predicted Range Differences S O'Reilly1*, L Yin2, A Kassaee1, Y Chang1, C Cheng3, J Zou1, T Li1, A Lin1, J Lukens1, R Lustig1, G Kurtz1, M Alonso-Basanta1, L Dong1, BK Teo1, (1) University of Pennsylvania, Philadelphia, PA, (2) Johns Hopkins Proton Therapy Center, Washington, DC, (3) Rutgers Cancer Institute of New Jersey, New Brunswick, NJ |